We observed no adverse effects on the quiescent host cells up to 100 μM, consistent with the fact that I-BET151 in known to be active in tumor cells and cancer cell lines in which c-MYC is overexpressed but not in a variety of other nonimmortalized cell types (18, –, 22). This evidence concerns the gene MYC and neoplasm.